Lucid Diagnostics (LUCD) Stock: Buy, Sell, or Hold?
LUCD - Lucid Diagnostics Inc. Common Stock
$0.84
0.04 (5.39%)
▲
5d:
+1.86%
30d:
-14.45%
90d:
-18.0%
WAIT
LOW Confidence
Analysis Updated: Sep 16, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When LUCD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: LUCD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: LUCD shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: LUCD is currently trading at $0.84, which is considered oversold relative to its 30-day fair value range of $0.86 to $1.01.
Technical Outlook: Technically, LUCD is in a strong downtrend. Immediate support is located at $0.75, while resistance sits at $0.99. The stock is showing strong short-term momentum, up 5.4% recently.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.00 (+404.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LUCD is in a strong downtrend. Immediate support is located at $0.75, while resistance sits at $0.99. The stock is showing strong short-term momentum, up 5.4% recently.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.00 (+404.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.86 -
$1.01
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.4%)
- BULLISH: Trading 404.0% below Wall St target ($4.00)
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.86 -
$1.01
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.75
Resistance Level
$0.99
Current Trend
Strong Downtrend
Technical data as of
Sep 16, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.81
Wall Street Target
$4.00
(+404.0%)
Revenue Growth (YoY)
26.7%
Share & Embed Analysis
Last updated: September 16, 2026 4:44 PM ET
Data refreshes hourly during market hours. Next update: 5:44 PM
Data refreshes hourly during market hours. Next update: 5:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LUCD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$62 | 61 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$376 | 56 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 51 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 47 HOLD |
